Anticipate generic drug launch
Drug patents …
… from Kazakhstan to Kalamazoo
Manage your formulary budget
Proactively manage your pharmacy inventory
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Find generic entry opportunities
|Title:||Inclusion complexes of aryl-heterocyclic salts|
|Abstract:||The esylate, mesylate, and tartrate salts of ziprasidone exhibit excellent solubilities in cyclodextrins.|
|Inventor(s):||Kim; Yesook (Branford, CT), Johnson; Kevin C. (Niantic, CT), Shanker; Ravi M. (Groton, CT)|
|Assignee:||Pfizer Inc. (New York, NY)|
1. A salt selected from ziprasidone esylate, ziprasidone mesylate, and ziprasidone tartrate.
2. A salt as defined in claim 1, which is ziprasidone esylate.
3. A salt as defined in claim 1, which is ziprasidone mesylate.
4. A salt as defined in claim 1, which is ziprasidone tartrate.